Scarica l'app Stockscreener
9.62
3.41%
-0.34
Dopo l'orario di chiusura:
9.65
0.03
+0.31%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ATRA Giù?
Forum
Previsione
Atara Biotherapeutics Inc Borsa (ATRA) Ultime notizie
Atara Biotherapeutics (ATRA) director awarded 24,000 restricted stock units - Stock Titan
Atara Biotherapeutics (NASDAQ: ATRA) director reports 38,320-share common stock holding - Stock Titan
Atara Biotherapeutics appoints Brian Cherry to board By Investing.com - Investing.com Australia
Atara Biotherapeutics Adds Independent Director to Board - TipRanks
Atara Biotherapeutics appoints Brian Cherry to board - Investing.com
New Atara (NASDAQ: ATRA) director and 2026 shareholder vote outcomes - Stock Titan
Atara Biotherapeutics Announces Changes to Its Board of Directors - The Joplin Globe
symbol__ Stock Quote Price and Forecast - CNN
Atara Biotherapeutics (ATRA) director granted 12,000 restricted stock units - Stock Titan
Atara Biotherapeutics (ATRA) director receives 12,000-share RSU grant - Stock Titan
Atara Biotherapeutics (ATRA) awards director 12,000 RSUs and reports fund holdings - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
ATRA: All proposals, including director elections and equity plan amendment, were approved - TradingView
Atara Biotherapeutics, Inc. (ATRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Atara Biotherapeutics Inc Annual Shareholders Meeting Transcript - GuruFocus
2026-06-09 | Atara Biotherapeutics, Inc. (ATRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ATRA | Press Release - Stockhouse
(ATRA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Connect - ACCESS Newswire
2026-06-07 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Connect | NDAQ:ATRA | Press Release - Stockhouse
ATRA stock shoots up 82% in a month: Here's what you should know - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
2026-06-04 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Stockholders to Learn More About the Investigation | NDAQ:ATRA | Press Release - Stockhouse
Atara Biotherapeutics, Inc. Common Stock (ATRA) Stock Price Today & Analysis - Gotrade
ATRA News | ATARA BIOTHERAPEUTICS INC (NASDAQ:ATRA) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeutics, Inc. (ATRA) Investors to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeuti - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Reach Out - ACCESS Newswire
2026-05-31 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Reach Out | NDAQ:ATRA | Press Release - Stockhouse
Atara Biotherapeutics (ATRA) Drops Over 6% as Stock Nears Critical Support LevelStandard Deviation - newsline.com
How (ATRA) Movements Inform Risk Allocation Models - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach Out - ACCESS Newswire
2026-05-28 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach Out | NDAQ:ATRA | Press Release - Stockhouse
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. LawsuitATRA - Morningstar
Atara Biotherapeutics (ATRA) Faces Selling Pressure Near Key Resistance ZoneNews Sentiment - newsline.com
ATRA FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 - New Castle News
Atara Biotherapeutics Analyst Ratings and Price Targets | NASDAQ:ATRA - Benzinga
ATRA DEADLINEFINAL REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts Atara Biotherapeutics, Inc. Investors to Participate in the Class Action Lawsuit Today - ACCESS Newswire
ATRA Deadline: Rosen Law Firm Urges Atara Biotherapeutics, Inc. (NASDAQ: ATRA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - New Castle News
Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
ATRA FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Atara Bi - GuruFocus
ATRA DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages - GlobeNewswire
ATRA DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Atara Biotherapeutics, Inc. Investors to Join the Class Action Lawsuit Today - ACCESS Newswire
ATARA DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class ActionATRA - TMX Newsfile
ATRARA (NASDAQ:ATRA) DEADLINE MAY 22nd: Bragar Eagel & - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain OfficersATRA - PR Newswire
Bronstein, Gewirtz & Grossman LLC Urges Atara - GlobeNewswire
ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know - The Globe and Mail
ATRA EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Atara - GuruFocus
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
ATRA EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 - PR Newswire
Atara Biotherapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before May 22, 2026 to Discuss Your RightsATRA - PR Newswire
Atara Biotherapeutics CAO sells $22,036 of company stock By Investing.com - Investing.com Canada
Atara Biotherapeutics CEO AnhCo Nguyen sells $47,844 in stock By Investing.com - Investing.com South Africa
Atara Biotherapeutics CEO AnhCo Nguyen sells $47,844 in stock - Investing.com
Atara (ATRA) CEO sells 5,241 shares in automatic tax sale - Stock Titan
Atara Biotherapeutics (ATRA) CAO sells 2,414 shares to cover RSU tax - Stock Titan
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):